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Abstract 
The primary objective of this study was to assess determinants of vaccine uptake in adults 
living in Germany exemplified by one standard vaccination (tetanus) and one vaccination 
targeting specific risk-groups (seasonal influenza). Data from 21,262 telephone household-
interviews representative of the adult population in Germany were collected in 2009 and 
analyzed. A total 73.1% of the adult population had a sufficient tetanus vaccination status 
according to national recommendations (i.e. last tetanus shot ≤10 years ago). Influenza 
vaccination coverage in the target population (i.e. persons ≥60 years, chronically ill, 
healthcare workers) was 44.1%. Persons who received professional vaccination advice within 
the past five years were more frequently vaccinated against tetanus and influenza than persons 
without (p<0.001). Private physicians were identified as the most important source for 
vaccination advice. Having a statutory health insurance, last physician contact <1 year ago, 
and living in the eastern part of Germany were independently associated with higher tetanus 
and influenza vaccine uptake. Low socio-economic status, two-sided migration background, 
and the feeling of being insufficiently informed on the benefits of vaccination were 
independently associated with low uptake of tetanus but not influenza vaccines. Our results 
show that tetanus vaccination coverage in the general adult population and influenza 
vaccination coverage in the target population are unsatisfactorily low in Germany. Since 
physicians’ advice has a major impact on the vaccination decision, physician reminder 
systems could provide a method to increase vaccination coverage in adults. For tetanus, 
information activities should target population groups with an increased risk of being 
undervaccinated.  
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Introduction 
With the success of vaccines in reducing the burden of various diseases, the threat 
posed by these diseases is less imminent and the benefits of vaccination programs are 
becoming less obvious to the public. To achieve high vaccination coverage in the target 
population for which a particular vaccination is recommended poses a challenge to public 
health authorities. Reliable data on the incidence and trends of vaccine-preventable diseases 
as well as on vaccination coverage in the target populations are needed to evaluate and, if 
necessary, to adjust vaccination programs by implementing appropriate strategies. In this 
context, the assessment of the impact of socio-economic, regional, informational and other 
health-relevant factors on vaccination coverage is important to identify potential barriers to 
high vaccine uptake. 
In Germany, the Standing Committee on Vaccination (STIKO) develops and endorses 
vaccination recommendations on a national level.1 The sixteen federal states in Germany are 
responsible for the implementation of vaccination programs. Vaccines for adults are usually 
administered by general practitioners and in some companies also by occupational physicians. 
There are two different health insurance schemes in Germany: the statuary health insurance 
(SHI) and the private health insurance (PHI) scheme. Approximately 90% of the German 
population is covered by a SHI.2 STIKO-recommended vaccinations are free of charge for 
both, persons who are covered by SHI and by PHI. However, persons with PHI need to pay 
for the vaccine and its administration out-of-pocket, and reimbursement of these expenses 
takes place after the bills are submitted to the insurance company. In contrast, persons with 
SHI are not involved in any payments of the physician or the vaccines. 
Tetanus and influenza are two diseases that can effectively be prevented by 
vaccination. In Germany, tetanus booster vaccination is recommended by STIKO to be given 
to all adults every ten years.1 Between 2001 and 2009, there were up to 32 reported cases of 
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tetanus each year, which occurred mainly among elderly persons.3, 4 However, the disease is 
notifiable only in 6 of the 16 federal states. Estimates of annual tetanus case numbers are 
therefore based on notification data from the respective states5 as well as on case reports4 and 
national hospital discharge statistics.3 Influenza vaccination is recommended for defined 
target groups who have either an increased risk for severe influenza disease (e.g. person with 
chronic underlying diseases, pregnant women, and persons ≥60 years of age) or who are 
likely to transmit the virus to vulnerable groups (e.g. health care workers).1 Depending on the 
intensity of influenza-activity there are between zero and approximately 30,000 estimated 
excess deaths attributable to influenza in Germany each year.6  
Germany has no central immunization registry. Data on vaccination coverage of 
children is systematically collected only at school entry when the children are between 5 and 
6 years of age.7 Information on vaccination coverage in adolescents and adults have mainly 
been available from a few smaller telephone surveys8-11, from health insurance companies12 
and household surveys (Microcensus 2003)13, and are largely insufficient. 
With the implementation of the ‘German Health Update’ Survey (GEDA) in 
2008/2009 as a part of the national health monitoring, a tool is now available in Germany for 
the detailed assessment of vaccination coverage in all age-groups above 18 years. GEDA is a 
large, population-representative telephone-survey. Here we present results from GEDA 2009 
with focus on one standard vaccination for adults (tetanus) and one vaccination targeting 
specific risk groups (influenza). While target-group specific influenza vaccination coverage 
based on GEDA 2009-data was subject of a previous publication14, this paper focuses in detail 
on factors influencing tetanus and seasonal influenza vaccine uptake. The objectives of this 
study were i) to assess the proportion of adults who were vaccinated against tetanus and 
seasonal influenza according to national recommendations, and ii) to identify factors 
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potentially associated with vaccine uptake in the target populations thereby generating 




 Sample characteristics. In total, 21,262 persons were interviewed via telephone 
during the study period of GEDA 2009 (July 2008-June 2009). Response Rate 3 as defined by 
the American Association for Public Opinion Research (AAPOR) was 29.1% and the 
cooperation rate at respondent level was 51.2%.14, 15 An overview of the study sample and the 
adult population in Germany (data of the German Federal Statistical Office, 2008) is given in 
Table 1. The median age in the study sample was 48.0 years (range 18-100 years). All data 
presented in the following sections are weighted data. 
  Tetanus vaccination coverage. Information on tetanus vaccination status (last tetanus 
shot > or ≤10 years ago) was available for 20,470 respondents (96.3% of the study 
population). A total 73.1% (95% confidence intervall (CI) 72.3-74.0) had a sufficient tetanus 
vaccination coverage according to the national recommendation (last tetanus shot ≤10 years 
ago). Tetanus vaccination coverage decreased with age and was lowest in persons ≥70 years 
(Figure 1). Among 20,840 respondents (98.0% of the study population) with information 
available, 95.4% (95%CI 95.0-95.9) stated to have received a tetanus shot at least once in 
their life. 
  The most frequently reported reason for receiving the last tetanus shot was that it was 
necessary due to the recommended immunization schedule (61.5%; 95%CI 60.6-62.4). A total 
31.4% (95%CI 30.6-32.3) reported to have received their last tetanus vaccination as part of an 
injury treatment, and 7.1% (95%CI 6.7-7.5) of the interviewed persons received it during a 
pre-travel health consultation. Respondents belonging to the first group were significantly 
more frequently vaccinated as compared to those belonging to the second (tetanus vaccination 
coverage 82.9% vs. 68.6%; p<0.001) or third group (78.0%; p<0.001). The majority of 
interviewed persons (72.2%; 95%CI 71.3-73.0) reported to have received their last tetanus 
vaccination at their family doctor; 7.8% (95%CI 7.3-8.3) received it at some other private 
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physician, 14.2% (95%CI 13.5-14.9) received it at a hospital emergency unit after injury, and 
2.6 (95%CI 2.3-2.9) received it at the local public health service.  
  Seasonal influenza vaccination coverage. Influenza vaccination status (vaccinated or 
unvaccinated for the last influenza season) was available for 21,190 interviewed persons 
(99.7%). Of those 10,640 (50.2%; 95%CI: 48.9-50.7) belonged to at least one of the 
recommended target groups for influenza vaccination. Influenza vaccination coverage was 
44.1% (95%CI 42.7-45.4) in persons belonging to the target population and 17.0% (95%CI 
16.2-17.9) in the non-target population. In contrast to tetanus vaccination, influenza 
vaccination coverage increased with age and was highest in persons ≥70 years (Figure 1). 
Among the different target groups, vaccination coverage was highest in persons ≥60 years 
(56.3%; 95%CI 54.5-58.1) and lowest in healthcare workers (HCW) (22.2%; 95%CI 19.7-
25.0). The proportion vaccinated was 44.5% (95%CI 42.8-46.1) among persons with 
underlying chronic diseases. 
 
Factors associated with tetanus and seasonal influenza vaccine uptake. Results of 
univariate and multivariate analysis of factors potentially associated with tetanus and seasonal 
influenza vaccine uptake are presented in Table 2 and Table 3 respectively. Several factors 
were independently associated with both higher tetanus and influenza vaccine uptake 
including having a SHI, having received a professional vaccination advice within the past five 
years, physician contact in the last 12 months, and caring about personal health. Unlike 
influenza vaccination coverage, tetanus vaccination coverage decreased with increasing size 
of the city of residency and with age. Women were significantly less frequently vaccinated 
against tetanus but not influenza than men. Having a two-sided migration background 
decreased the odds of being vaccinated against tetanus by 40% when compared to persons 
without migration background.  
 8/25
Vaccination consultation and perceived information status. Receiving professional 
vaccination advice was independently associated with both, higher influenza and tetanus 
vaccine uptake (Tables 2 and 3). A total 56.0% (95%CI 55.2-56.9) of the interviewed persons 
reported to have received vaccination advice within the past five years. The most frequently 
reported source of vaccination advice was with 95.1% (95%CI 94.7-95.6) ‘general 
practitioners’. Health insurance companies (reported by 2.5% of interviewed persons who 
received consultation) and official health authorities (1.6%) played only a minor role as 
source of vaccination advice. 
A total 87.9% (95% CI 87.2-88.4) of respondents had at least one physician contact in 
the last 12 months, 10.6% (95% CI 10.1-11.2) of respondents reported that their last physician 
contact was between 1 and 5 years ago, and 1.5% (95% CI 1.3-1.8) reported that it was longer 
than 5 years ago. Persons who had a physician contact in the last 12 months received 
significantly more often professional vaccination advice (58.1% reported such an advice) than 
persons whose last physician contact was between 1 to 5 years ago (42.9%; p<0.001) or more 
than 5 years ago (30.0%; p<0.001). 
Of all interviewed persons 79.3% (95%CI 78.6-80.0) felt sufficiently informed about 
the benefits of vaccination in general, and 62.2% (95% CI 61.3.0-63.0) felt sufficiently 
informed about the risks of vaccination. Persons, who received professional vaccination 
advice, felt significantly more often sufficiently informed about the benefits (91.9% vs. 
63.2%; p<0.001) and risks (74.1% vs. 46.8%; p<0.001) of vaccination than person without 
professional vaccination advice in the past 5 years.  
Respondents with a two-sided migration background felt significantly less often 
sufficiently informed about the benefits and risks of vaccination (63.2% and 47.2%), and 
received significantly less often professional vaccination advice (45.2%) when compared to 
persons with a one-sided or no migration background (for all p<0.001). Similar observations 
were found for persons with a low socioeconomic status (74.2% and 56.2%; with 49.9% 
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having received advice) when compared to persons with a medium or high socio-economic 




Due to the lack of an immunization registry in Germany, up-to-date country-level data 
on vaccination coverage in the general adult population and in specific vaccination target 
groups have to be assessed by surveys.7, 16 With GEDA a large data source consisting of more 
than 21.000 interviews representative of the adult population in Germany is now available 
since 2009. It is the only data source for tetanus vaccination coverage in the adult population 
living in Germany for more than a decade. We were able to demonstrate that tetanus and 
seasonal influenza vaccination coverage in the target populations are unsatisfactorily low in 
Germany. Moreover, our study revealed a lack of knowledge in the population regarding 
information about the benefits and risks of vaccination, demonstrated the importance of 
private physicians as the main source of vaccination advice, and identified several potential 
barriers to tetanus and influenza vaccine uptake. 
In accordance with other studies,17-19 receiving vaccination consultation was shown to 
be a strong enabling factor for both high influenza and tetanus vaccine uptake in our study. 
Persons who received a professional advice did not only feel better informed about the 
benefits but also about the risks of vaccination in general. Since only 56% of the respondents 
of this study received a vaccination advice in the past five years but 98% had visited a 
physician in this period, it is important to ensure that every contact with a physician is used to 
check vaccination status. Private physicians stood out as the main source of vaccination 
information and consultation for the general adult population. Therefore it is crucial to 
provide HCWs – especially private physicians – with information about vaccines and the 
respective vaccine-preventable diseases that is based upon current scientific evidence.20 
Furthermore, HCWs should be enabled to adequately advice and inform patients regarding 
vaccination.  
Differences in factors being associated with seasonal influenza and tetanus vaccine 
uptake have been identified. For influenza vaccination, higher coverage was identified in 
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older people, in individuals with underlying chronic diseases, and in persons without 
perceived good health status. In contrast, higher tetanus vaccination coverage was associated 
with younger age, and not with perceived health status or chronic underlying diseases. These 
differences can be explained by the fact that seasonal influenza vaccination is recommended 
for specific risk groups, mainly older persons and persons with chronic underlying diseases. 
The last nationwide assessment of tetanus vaccination coverage among adults was 
conducted in 1998 and revealed with 63% a lower coverage as compared to our assessment 
(73.1%).21 Current tetanus vaccination coverage in Germany is comparable to tetanus 
coverage in other European countries and the US. A study based on patient data collected in a 
Spanish medical emergency service in 2007 revealed among adults a tetanus vaccination 
coverage of 71.6% (95% CI: 68.3–74.8).22 Based on data of the 2002 Health and Social 
Protection Survey, a tetanus vaccination coverage of 62.3% (95%CI 61.1-63.5) was estimated 
for adults living in France.23 In the United States tetanus vaccine uptake was reported to be 
61.6 % (95%CI: 60.6-62.5) in adults ≥18 years based on data of the National Health Interview 
Survey 2008.24 In all three surveys a sufficient tetanus vaccination status was defined as 
having received the last tetanus shot ≤10 years ago. In our study we observed that tetanus 
vaccine uptake decreased with age. This observation was also made in other industrialized 
countries 24, 25 and is congruent to the fact that tetanus infections mainly occur among elderly 
persons in Germany.4 Thus, particularly older age-groups should be the target of individual 
tetanus vaccination catch-up activities. 
Another important finding of our study was that persons with a SHI were significantly 
more likely to have a sufficient tetanus vaccination status than persons covered by PHI. The 
same observation was made for influenza vaccination among persons with an indication for 
this vaccination. A possible explanation for this finding, which remained stable in the 
multivariate analysis as an independent factor, might be that in Germany it is more 
complicated and time-consuming for someone with a PHI to receive the vaccination and to 
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get the expenses reimbursed. Persons with PHI need to pay for the vaccine out-of-pocket, and 
reimbursement takes place not until the bills are send to the PHI. In addition, persons covered 
by SHI usually receive a vaccine dose from the physician’s stock, whereas persons with PHI 
sometimes need a prescription from the physician first, then they need to go to the pharmacy 
to buy the vaccine, and finally they need to go back to the physician for the administration of 
the vaccine. 
In our study, having a two-sided migration background was identified as a barrier to 
sufficient vaccination information and consultation as well as to tetanus vaccination. The 
latter observation is concordant with the findings of the ‘German Health Interview and 
Examination Survey for Children and Adolescents’ (KiGGS), which revealed significantly 
lower tetanus vaccination coverage (defined as a completed primary series of tetanus-
preventing vaccinations) in adolescents aged 14-17 years when compared to those without 
migration background (~89% vs. ~97%).26 In the same survey insufficient vaccination 
coverage in adolescents (11-17 years) with migration background was detected for the 
vaccinations against Diphtheria, Haemophilus influenzae and Poliomyelitis,26 and in foreign 
born children (2-17 years) for the vaccination against measles.27 However, it should be noted 
that the sub-population ‘persons with a two-sided migration background’ is very 
heterogeneous. Therefore, the reasons for low vaccine uptake in this specific population are 
likely to be diverse.  
Since STIKO-recommended vaccinations are free of charge in Germany, we did not 
expect that low socioeconomic status would be a barrier to basic vaccinations. Our results 
from multivariate analyses showed, however, that persons with a low socioeconomic status 
were significantly less often vaccinated against tetanus and received less frequently 
professional vaccination advice when compared to persons with a medium or high 
socioeconomic status. This was, however, different for influenza vaccine uptake, which was 7 
percentage points higher in persons with low when compared to persons with high 
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socioeconomic status (significant in bivariate but not multivariate analysis). Further research 
with focus on potential barriers to adult vaccination in different sub-groups of migrants as 
well as persons with low socioeconomic status is therefore necessary. 
In our study significantly higher vaccination coverage was found in the eastern part of 
Germany for both vaccinations under investigation. Possible reasons for this observation have 
been discussed in detail in previous publications.8, 9, 14 In brief, mandatory vaccination 
practices in the former German Democratic Republic as well as differences in current 
implementation practices on the federal state level may contribute in general to a higher 
acceptance of vaccinations in the eastern federal states.  
Our study has several limitations that need to be acknowledged. With 29.1% the 
response rate (Response Rate 3 as defined by AAPOR15) was comparatively low. However, it 
should be mentioned that the chosen method of calculating a response rate is a very 
conservative approach and that the response rate in our study is comparable to other studies 
using this approach (e.g. CDC-Behavioral Risk Factor Surveillance System Report28). 
Considering the complex weighting procedures utilised in GEDA 2009 and the good 
cooperation rate (51.2%)14 it can be assumed that data quality in terms of generalizability to 
the general adult population is overall good (compare Table 1). Since vaccination status was 
self-reported by the respondents it could not be corroborated by any medical records. 
However, several previous studies have found that self-report of recent influenza vaccination 
has an adequate degree of validity.29, 30 It is also likely that accuracy of self-reporting for 
having received a seasonal influenza shot for the last season differs from that for having 
received tetanus vaccination within the past 10 years. The estimates for tetanus vaccination 
coverage might therefore have been more prone to recall bias than those for influenza 
vaccination. Finally, persons with insufficient knowledge of the German language or persons 
who could not be interviewed via telephone were excluded from our study.  
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Methods 
Study population and survey design. Details of the GEDA 2009 survey design have 
been described previously.14 In brief, GEDA 2009 is a national health telephone survey, 
representative of the adult population in Germany, which was conducted between July 2008 
and June 2009. The study population (n=21,262) included persons 18 years of age or older 
who were living in a private household in Germany and who were able to be contacted by 
landline telephone. Persons aged ≤17 years and persons with an insufficient knowledge of the 
German language were excluded from the survey. The study protocol was approved by 
Germany's federal and regional data-protection commissioners. All data were collected and 
analyzed in an anonymous manner.  
Response rates were calculated using Response Rate 3 as defined by the American 
Association for Public Opinion Research (AAPOR).15 Response Rate 3 is defined as the 
number of complete interviews divided by the number of interviews plus the number of non-
interviews plus cases of unknown eligibility. Response Rate 3 uses an estimate for the 
proportion of cases of unknown eligibility that is potentially eligible. The cooperation rate at 
respondent level is defined as the proportion of all cases interviewed of all respondents ever 
contacted. This rate is calculated using only contacts with and refusals from known 
respondents.15 
Definition of variables. All participants were asked whether they were vaccinated 
against seasonal influenza during the last season (Appendix). Since survey respondents were 
contacted over a 12-month period, the ‘last’ influenza season is either season 2007/08 or 
2008/09 – depending on point of time of interview. Univariate and multivariate analysis of 
factors potentially influencing influenza vaccine uptake was performed using the complete 
dataset without consideration of season. Influenza vaccination coverage was calculated for 
persons for whom influenza vaccination is recommended in Germany. In accordance with the 
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STIKO 2008/09 recommendations1, we classified persons into the influenza vaccination 
target group if they reported (1) to be ≥60 years of age, (2) to have underlying chronic 
diseases (chronic underlying respiratory, cardiovascular, liver or renal disease, cancer or 
diabetes), or (3) to work as a healthcare professional. Due to the study design, persons living 
in nursing or old people’s homes, for which influenza vaccination is also recommended by 
STIKO, were included in the survey but not specifically asked if they live in such a home. 
Therefore, persons belonging to this target group were not identified and analyzed as a 
separate target group. Persons were regarded as vaccinated against tetanus if they reported to 
be vaccinated during the past 10 years. Persons were regarded as unvaccinated if they 
reported to have never received a tetanus vaccination or if the last tetanus shot was longer 
than 10 years ago. Persons were neither asked whether tetanus or influenza vaccination was 
offered to them nor if they actively declined a vaccination offer. 
Socio-economic status levels were created as described by Lampert and Kroll on the 
basis of self-reported educational, income, and professional status of the interviewed person.32 
The geographic region category ‘Northwest/Middle’ comprises the German federal states 
Schleswig-Holstein, Bremen, Lower Saxony, Hesse, Rhineland-Palatinate and Saarland (adult 
population: ~20 million), ‘Midwest’ comprises North Rhine-Westphalia (~15 million), ‘East’ 
comprises Mecklenburg-Vorpommern, Brandenburg, Berlin, Saxony-Anhalt, Thuringia and 
Saxony (~ 14 million), and ‘South’ comprises Baden-Württemberg and Bavaria (~ 19 
million).  
Interviewed persons were asked about the type of their health insurance (SHI, PHI, or 
other, which is defined as no health insurance, foreign health insurance, or unknown health 
insurance status) and potential migration background (none, one-sided when one parent and 
two-sided when both parents or the respondent were born abroad). Further questions included: 
Caring about personal health (yes/no); Self-assessment of general health status (good/not 
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good); Smoking behaviour (current or past smoker/non-smoker); Alcohol consumption 
(regular/ never or occasional). Finally, interviewees were asked questions related to 
vaccination: Received professional vaccination advice within the last five years (yes/no); 
source of vaccination advice (general practitioner, health insurance company, official health 
authorities, other); feeling sufficiently informed about the benefits of vaccination in general / 
feeling sufficiently informed about potential harms of vaccination in general (yes/no). 
Respondents were not explicitly asked to review their medical records before responding. 
 
Statistical analysis. Data were analysed using PASW version 18.0 for Windows (SPSS Inc., 
Chicago, USA). Univariate analyses were performed to determine the association between 
vaccination uptake and demographic, socio-economic, health-relevant and informational 
factors. A p-value ≤0.05 was considered to indicate a statistically significant difference. Odds 
ratios (OR) and 95% confidence intervals (CI) were calculated as appropriate. Variables 
potentially associated with vaccine uptake (p-value <0.2 in univariate analysis) were entered 
into a multivariate logistic regression model in a first step, followed by step-wise backward 
removal of variables with a p-value >0.05 to produce a final model. 
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Conclusion. Despite an increase in tetanus and seasonal influenza vaccination coverage in 
German adults within the past ten years,11, 21 our results indicate that tetanus vaccination 
coverage in the general adult population and influenza vaccination coverage in the target 
population is still unsatisfactorily low in Germany. Measures such as offering low-threshold 
vaccination services, implementing reminder systems for clients (potential vaccinees) and 
providers (physicians), and target group-oriented education strategies have been shown to 
improve vaccine uptake31 – especially when they are applied in combination – and should 
therefore be enhanced in Germany. As highlighted by the results of our study, private 
physicians should be a main target for enhanced activities related to vaccinations in Germany, 
since they are key figures in advising adults about vaccinations and informing them about the 
harms and benefits of the vaccines. In our study population, 88% had visited a physician in 
the past 12 months for any reason. Further research is necessary to evaluate communication 
channels for the efficient provision of vaccine-related information to private physicians and to 
assess their needs regarding vaccination-related information as well as patient recall and 
reminder systems.
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Characteristics of persons aged ≥18 years in the study sample and the general population, Germany, 2008/09 
Characteristics  Study population GEDA 09* 
(n=21,262) 
 General population, 2008** 
(n=68,318,799) 
  n  % (95% CI)  n  % 
Sex         
   Male  10,310  48.5 (47.6-49.4)  33,165,264  48.5 
   Female  10,952  51.5 (50.6-52.4)  35,153,535  51.5 
Age         
   18-39 years    7,021  33.0 (32.2-33.8)  22,135,423  32.4 
   40-59 years    7,774  36.6 (35.7-37.4)  25,225,632  36,9 
   ≥60 years    6,467  30.4 (29.5-31.3)  20,957,744  30.7 
Geographic Region         
   Northwest/Middle    6,263  29.5 (28.7-30.3)  20,126,061  29.5 
   Midwest    4,598  21.6 (20.9-22.4)  14,764,121  21.6 
   East    4,467  21.0 (20.3-21.7)  14,306,153  20.9 
   South    5,934  27.9 (27.1-28.7)  19,122,464  28.0 
Target group for influenza 
vaccination 
        
   Healthcare workers       996    4.7 (4.4-5.0)    3,060,000    4.5 
   Persons with underlying  
   chronic conditions 
   6,959  32.7 (31.9-33.6)  unknown   
   Whole target population  
 
 10,661  50.1 (49.3-51.0)  unknown   




Univariate and multivariate analysis of factors potentially associated with tetanus vaccination 
coverage in the general population  
 
Variable  Vaccination coverage (%)  
Univariate 
OR (95% CI)  
Multivariate 
OR (95% CI) 
Sex       
female  71.6  1 (ref)  1 (ref) 
male  74.8  1.18 (1.11-1.25)**  1.20 (1.11-1.29)** 
Age       
18-39  77.3  1 (ref)  1 (ref) 
40-59  74.8  0.87 (0.80-0.94)**  0.82 (0.75-0.90)** 
≥60  66.7  0.59 (0.54-0.63)**  0.46 (0.42-0.51)** 
Geographic Region       
Northwest/Middle  71.8  1 (ref)  1 (ref) 
Midwest  66.9  0.80 (0.73-0.87)**  0.90 (0.81-0.99)* 
East  79.2  1.50 (1.37-1.64)**  1.37 (1.23-1.52)** 
South  74.7  1.16 (1.07-1.26)**  1.07 (0.97-1.17) 
Residency (population)       
<5,000  77.6  1 (ref)  1 (ref) 
5,000-<20,000  74.4  0.84 (0.76-0.92)**  0.93 (0.84-1.04) 
20,000-<100,000  73.3  0.79 (0.72-0.87)**  0.84 (0.76-0.93)* 
≥100,000  69.4  0.66 (0.60-0.72)**  0.68 (0.62-0.75)** 
Type of health insurance       
PHI  71.3  1 (ref)  1 (ref) 
SHI  73.2  1.10 (1.00-1.21)  1.26 (1.12-1.41)** 
other  77.4  1.37 (1.11-1.69)*  1.24 (0.97-1.60) 
Received vaccination advice within 
past 5 years 
      
no  58.2  1 (ref)  1 (ref) 
yes  84.8  4.00 (3.74-4.28)**  3.37 (3.12-3.64)** 
Feel sufficiently informed about the 
benefits of vaccination 
      
no  58.6  1 (ref)  1 (ref) 
yes  77.2  2.39 (2.22-2.56)**  1.52 (1.39-1.67)** 
Feel sufficiently informed about the 
risks of vaccination 
      
no  66.1  1 (ref)  NS 
yes  77.4  1.76 (1.65-1.87)**   
Last physician contact       
<1 year  74.7  1 (ref)  1 (ref) 
≥1 year - <5 years  64.1  0.60 (0.55-0.66)**  0.68 (0.61-0.76)** 
≥5 years  45.4  0.28 (0.23-0.35)**  0.29 (0.22-0.38)** 
Socioeconomic Status       
low  67.4  1 (ref)  1 (ref) 
medium  74.1  1.39 (1.29-1.50)**  1.17 (1.06-1.28)* 
high  76.0  1.54 (1.39-1.69)**  1.18 (1.04-1.33)* 
Migration background       
none  75.2  1 (ref)  1 (ref) 
one-sided  75.7  1.03 (0.86-1.23)  1.00 (0.81-1.22) 
two-sided  59.1  0.48 (0.44-0.52)**  0.60 (0.53-0.67)** 
Caring about personal health       
no  70.5  1 (ref)  1 (ref) 
yes  75.4  1.28 (1.20-1.36)**  1.19 (1.11-1.29)** 
Smoking       
non-smoker  73.9  1 (ref)  1 (ref) 
current or past smoker  72.5  0.93 (0.88-0.99)*  0.91 (0.85-0.99)* 
Alcohol consumption       
never/occasional  72.2  1 (ref)  1 (ref) 
regular  75.7  1.20 (1.12-1.29)**  1.17 (1.07-1.27)** 
Underlying chronic disease       
no  73.3  1 (ref)  NS 
yes  72.9  0.98 (0.92-1.04)   
Perceived general health status       
not good  69.5  1 (ref)  NS 
good  74.7  1.30 (1.22-1.39)**   
OR=Odds Ratio; CI=Confidence Interval; ref = reference category; PHI=private health insurance; SHI=statutory health 




Univariate and multivariate analysis of factors potentially associated with influenza vaccination 
coverage in the recommended target population  
 
Variable  Vaccination coverage (%)  
Univariate 
OR (95% CI)  
Multivariate 
OR (95% CI) 
Sex       
female  44.5  1 (ref)  NS 
male  43.5  0.96 (0.89-1.04)   
Age       
18-39  17.5  1 (ref)  1 (ref) 
40-59  30.0  2.02 (1.73-2.35)**  2.02 (1.71-2.38)** 
≥60  56.3  6.07 (5.29-6.95)**  6.55 (5.64-7.61)** 
Geographic Region       
Northwest/Middle  40.2  1 (ref)  1 (ref) 
Midwest  43.1  1.13 (1.01-1.25)*  1.20 (1.06-1.36)* 
East  58.9  2.13 (1.91-2.38)**  2.00 (1.76-2.27)** 
South  37.9  0.91 (0.82-1.01)  0.90 (0.80-1.01) 
Residency (population)       
<5,000  45.1  1 (ref)  NS 
5,000-<20,000  43.5  0.94 (0.84-1.05)   
20,000-<100,000  43.7  0.95 (0.85-1.06)   
≥100,000  44.0  0.96 (0.86-1.07)   
Type of health insurance       
PHI  37.2  1 (ref)  1 (ref) 
SHI  45.1  1.39 (1.22-1.58)**  1.32 (1.14-1.53)** 
other  31.8  0.79 (0.57-1.08)  1.03 (0.72-1.47) 
Received vaccination advice within 
past 5 years 
      
no  29.3  1 (ref)  1 (ref) 
yes  54.7  2.90 (2.67-3.15)**  3.05 (2.77-3.35)** 
Feel sufficiently informed about the 
benefits of vaccination 
      
no  29.9  1 (ref)  NS 
yes  47.1  2.09 (1.88-2.34)**   
Feel sufficiently informed about the 
risks of vaccination 
      
no  36.7  1 (ref)  1 (ref) 
yes  47.5  1.56 (1.43-1.69)**  1.16 (1.05-1.29)* 
Last physician contact       
<1 year  46.4  1 (ref)  1 (ref) 
≥1 year - <5 years  19.6  0.28 (0.24-0.34)**  0.37 (0.30-0.44)** 
≥5 years  26.7  0.42 (0.28-0.63)**  0.44 (0.27-0.70)* 
Socioeconomic Status       
low  47.7  1 (ref)  NS 
medium  43.7  0.85 (0.78-0.93)*   
high  40.3  0.74 (0.66-0.84)**   
Migration background       
none  45.0  1 (ref)  1 (ref) 
one-sided  44.0  0.96 (0.78-1.19)  1.00 (0.78-1.28) 
two-sided  35.9  0.69 (0.60-0.78)**  1.23 (1.05-1.44)* 
Caring about personal health       
no  38.0  1 (ref)  1 (ref) 
yes  48.4  1.53 (1.42-1.66)**  1.26 (1.15-1.38)** 
Smoking       
non-smoker   48.6  1 (ref)  1 (ref) 
current or past smoker  40.1  0.71 (0.66-0.76)**  0.91 (0.83-1.00)* 
Alcohol consumption       
never/occasional  44.2  1 (ref)  NS 
regular  43.2  0.96 (0.88-1.05)   
Underlying chronic disease       
no  35.9  1 (ref)  1 (ref) 
yes  50.9  1.85 (1.71-2.00)**  1.37 (1.24-1.51)** 
Perceived general health status       
not good  52.7  1 (ref)  1 (ref) 
good  37.5  0.54 (0.50-0.58)**  0.72 (0.65-0.79)** 
OR=Odds Ratio; CI=Confidence Interval; ref = reference category; PHI=private health insurance; SHI=statutory health 
insurance; NS=not significant; *p<0.05; **p<0.001 
 
